No photo of Richard Ebright
Contact Expert

View Scopus Profile

Richard Ebright

Rutgers, The State University

 https://orcid.org/0000-0001-8915-7140
    • 12270 Citations
    • 65 h-Index
    1981 …2023
    If you made any changes in Pure, your changes will be visible here soon.

    Fingerprint Dive into the research topics where Richard Ebright is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

    • 7 Similar Profiles
    DNA-Directed RNA Polymerases Medicine & Life Sciences
    Cyclic AMP Receptor Protein Medicine & Life Sciences
    DNA Medicine & Life Sciences
    Bacterial RNA Medicine & Life Sciences
    Transcriptional Activation Medicine & Life Sciences
    Transcription Chemical Compounds
    Proteins Medicine & Life Sciences
    Amino Acids Medicine & Life Sciences

    Network Recent external collaboration on country level. Dive into details by clicking on the dots.

    Projects 1988 2023

    DNA SEQUENCE RECOGNITION BY CAP

    Ebright, R.

    National Institutes of Health

    12/1/88 → 1/31/23

    Rutgers, The State University

    Project: Research project

    DNA-Directed RNA Polymerases
    DNA
    Cyclic AMP Receptor Protein
    DNA sequences
    Transcriptional Activation

    Therapeutics For Drug Resistant-Bacteria: Arylpropionyl-Phloroglucinols

    Ebright, R.

    National Institutes of Health (NIH)

    4/25/14 → 3/31/18

    Rutgers, The State University

    Project: Research project

    Phloroglucinol
    National Institute of Allergy and Infectious Diseases (U.S.)
    DNA-Directed RNA Polymerases
    Bacteria
    Rifampin

    Center to develop therapeutic countermeasures to high-threat bacterial agents

    Ebright, R., Freundlich, J., Alland, D. & Perlin, D.

    National Institutes of Health

    4/25/14 → 11/30/19

    Rutgers, The State University

    Project: Research project

    National Institute of Allergy and Infectious Diseases (U.S.)
    Anti-Bacterial Agents
    Phloroglucinol
    Drug Discovery
    Pharmaceutical Preparations

    Therapeutics For Drug-Resistant Bacteria: Pseudouridimycins

    Ebright, R.

    National Institutes of Health (NIH)

    1/15/13 → 12/31/18

    Rutgers, The State University

    Project: Research project

    DNA-Directed RNA Polymerases
    Bacteria
    Bacterial RNA
    Pharmaceutical Preparations
    Streptococcus

    Therapeutics for Drug-Resistant Bacteria: Pseudouridimycins

    Ebright, R.

    National Institutes of Health

    1/15/13 → 12/31/18

    Rutgers, The State University

    Project: Research project

    DNA-Directed RNA Polymerases
    Bacteria
    Bacterial RNA
    Pharmaceutical Preparations
    Streptococcus

    Research Output 1981 2019

    Discovery, properties, and biosynthesis of pseudouridimycin, an antibacterial nucleoside-analog inhibitor of bacterial RNA polymerase

    Ebright, R., Mar 29 2019, In : Journal of Industrial Microbiology and Biotechnology. 46, 3-4, p. 335-343 9 p.

    Rutgers, The State University

    Research output: Contribution to journal › Review article

    Bacterial RNA
    Biosynthesis
    DNA-Directed RNA Polymerases
    RNA
    Nucleosides
    2 Citations (Scopus)

    Functionalised bicyclic tetramates derived from cysteine as antibacterial agents

    Ebright, R. H., Jan 1 2019, In : Organic and Biomolecular Chemistry. 17, 22, p. 5615-5632 18 p.

    Rutgers, The State University

    Research output: Contribution to journal › Article

    cysteine
    DNA-Directed RNA Polymerases
    Skeleton
    Cysteine
    Bacteria

    RNA Polymerase Reaches 60: Transcription Initiation, Elongation, Termination, and Regulation in Prokaryotes

    Ebright, R. H., Sep 20 2019, In : Journal of molecular biology. 431, 20, p. 3945-3946 2 p.

    Rutgers, The State University

    Research output: Contribution to journal › Editorial

    3 Citations (Scopus)

    Structural basis of ECF-σ-factor-dependent transcription initiation

    Ebright, R. H., Dec 1 2019, In : Nature communications. 10, 1, 710.

    Rutgers, The State University

    Research output: Contribution to journal › Article

    Open Access
    DNA-Directed RNA Polymerases
    Transcription
    Transcription Factors
    Mycobacterium tuberculosis
    DNA
    2 Citations (Scopus)

    Structural basis of Q-dependent antitermination

    Ebright, R. H., Sep 10 2019, In : Proceedings of the National Academy of Sciences of the United States of America. 116, 37, p. 18384-18390 7 p.

    Research output: Contribution to journal › Article

    Open Access
    DNA-Directed RNA Polymerases
    Bacteriophages
    Sigma Factor
    RNA
    Gene Expression

    Press/Media

    Breakthrough In Identifying Molecular Target and Mode of Action of Fidaxomicin

    Richard Ebright

    3/30/18

    1 item of Media coverage

    Rutgers, The State University

    Press/Media: Press / Media

    Researchers define target and mechanism of antibacterial drug fidaxomicin (dificid)

    Richard Ebright

    3/29/18

    1 item of Media coverage

    Rutgers, The State University

    Press/Media: Press / Media

    Researchers define target and mechanism of antibacterial drug fidaxomicin (Dificid)

    Richard Ebright

    3/29/18

    1 item of Media coverage

    Rutgers, The State University

    Press/Media: Press / Media

    Targeting nature's greatest killer; Scientists use new tools to eradicate mosquito threat

    Richard Ebright

    10/13/17

    1 item of Media coverage

    Rutgers, The State University

    Press/Media: Press / Media

    Outbreak: Outwitting nature’s greatest killer

    Richard Ebright

    10/5/17

    1 item of Media coverage

    Rutgers, The State University

    Press/Media: Press / Media